Guardian Report: Inside one of the first licensed medical cannabis labs in Britain
Cannabis Law Report
MAY 9, 2022
The company is following in the footsteps of GW Pharmaceuticals, a trailblazer that developed the first cannabis-based medicine to be licensed in the UK in 2010, Sativex for multiple sclerosis, which costs about £2,000 a year. However, NHS prescribing of the mouth spray remains very limited and varies across the country.
Let's personalize your content